Adial Pharmaceuticals, Inc (ADIL) is a publicly traded Healthcare sector company. As of October 16, 2026, ADIL trades at $3.17 with a market cap of $8.80M and a P/E ratio of -0.34. ADIL moved +0.92% today. Year to date, ADIL is -47.51%; over the trailing twelve months it is -67.47%. Its 52-week range spans $1.31 to $32.50. Analyst consensus is buy with an average price target of $11.00. Rallies surfaces ADIL's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks hedge fund and 13F ownership for ADIL, including fund holders, share counts, and position changes when data is available.
| Metric | Value |
|---|---|
| Price | $3.17 |
| Market Cap | $8.80M |
| P/E Ratio | -0.34 |
| EPS | $-11.93 |
| Dividend Yield | 0.00% |
| 52-Week High | $32.50 |
| 52-Week Low | $1.31 |
| Volume | 34 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-7.98M |
| Gross Margin | 0.00% |
1 analysts cover ADIL: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $11.00.